Drugs / SK-PC-B70M
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 31 trial | ||||||
| Phase 3 | NCT01249196 | May 2010 → Aug 2013 | Alzheimer disease | SK Chemicals Co., Ltd. | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| Phase 2 | NCT00443417 Comparator | Apr 2007 → Jan 2009 | Alzheimer disease | SK Chemicals Co., Ltd. | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | SK-PC-B70M | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00443417 ↗ |